Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer [Phase 2]
Phase 2 trial of NIS793 in combination with FOLFIRINOX for pancreatic cancer was terminated, with results posted on 2024-07-16.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial of NanoPac in locally advanced pancreatic adenocarcinoma has completed, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 [Phase 2]
Phase 2 FLUOPANC trial evaluating fluorescence-guided surgery for pancreatic adenocarcinoma and cholangiocarcinoma using the fluorescent age…
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer [Phase 2]
Phase 2 trial evaluating epacadostat with pembrolizumab and CRS-207, with or without cyclophosphamide and GVAX Pancreas vaccine, in metastat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors [Phase 1]
Clinical trial update reporting completion of a Phase 1 study evaluating AB011 in CLDN18.2-positive advanced solid tumors including gastric …
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for a combination of liposomal irinotecan, fluorouracil, leucovorin, and rucaparib in pati…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating CEP-37250/KHK2804 in adults with advanced solid tumors has completed; the conditions include colorectal adenocarcin…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment [Phase 3]
Phase 3 study evaluating irinotecan liposome injection with 5-FU/leucovorin and oxaliplatin versus nab-paclitaxel plus gemcitabine in previo…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates [Phase 2]
A Phase 2 clinical trial evaluating perioperative therapy for resectable and borderline-resectable pancreatic adenocarcinoma with molecular …
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer [Phase 1, Phase 2]
Early-phase clinical trial update evaluating fluorescent navigation technology to aid radical resection in resectable pancreatic adenocarcin…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride with radiation therapy for borderline resectable pancreatic cancer (terminated; results p…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial investigating durvalumab with booster radiation in metastatic pancreatic adenocarcinoma was terminated; results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. [Phase 1, Phase 2]
Phase 1/2 trial update for MEDI9447 (oleclumab) in combination with pancreatic chemotherapy in metastatic pancreatic adenocarcinoma; study c…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating nab-paclitaxel and gemcitabine followed by AG-mFOLFOX in metastatic pancreatic adenocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") [Phase 2]
Phase 2 clinical trial exploring molecular profiling to guide therapy before and after surgery in pancreatic adenocarcinoma; results complet…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy [Phase 1, Phase 2]
Phase 1/2 study evaluating Niraparib in combination with Ipilimumab or Nivolumab in pancreatic adenocarcinoma after platinum-based chemother…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial investigating ramucirumab with nab-paclitaxel and gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial investigating BATS with low-dose IL-1 and GM-CSF in advanced pancreatic cancer (Phase 1/2) has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 trial assessing paclitaxel albumin-stabilized nanoparticles with or without AZD1775 in previously untreated metastatic or unresect…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial of ascorbic acid combined with nab-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update on intratumoral gene therapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX [Phase 3]
A Phase 3 trial comparing EndoTAG-1+GEM versus GEM in locally advanced or metastatic pancreatic adenocarcinoma after FOLFIRINOX failure has …
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for durvalumab plus CV301 with maintenance chemotherapy in metastatic colorectal or pancreatic adenocarcinoma; study s…